rs7305115
This is a synonymous variant in the TPH2 gene — it does not change the protein's amino acid sequence.
▶ClinVar annotation
▶Research that mentions this SNP (6)
▶Interaction among childhood trauma and functional polymorphisms in the serotonin pathway moderate the risk of depressive disordersAssociationN=4,504Sandra Van der Auwera et al.(2014)· European Archives of Psychiatry and Clinical Neuroscience
This gene-environment interaction study examined 4,504 Caucasian subjects from two independent cohorts (SHIP-LEGEND and SHIP-TREND-0) to assess how variants in serotonergic pathway genes TPH2 (rs7305115) and 5-HTTLPR moderate depression risk after childhood abuse. The three-way interaction between abuse, TPH2 GG genotype, and 5-HTTLPR SS genotype showed significant association with depression severity (p=0.023), with GG/SS carriers exposed to abuse displaying mean BDI-II scores of 15.0 compared to 6.8 in AA carriers, supporting the serotonin deficiency hypothesis in depression.
▶Involvement of tryptophan hydroxylase 2 (TPH2) gene polymorphisms in susceptibility to coronary artery lesions in Korean children with Kawasaki diseaseAssociationN=357Sung Wook Park et al.(2010)· European Journal of Pediatrics
This case-control study examined associations between TPH2 gene polymorphisms (rs7305115 and rs4290270) and Kawasaki disease with coronary artery lesions (CALs) in 101 Korean children versus 256 controls. While the SNPs showed no association with KD susceptibility itself, both SNPs demonstrated statistically significant associations with CAL development: rs7305115 AA genotype (OR=5.69, p=0.0004) and rs4290270 AA genotype (OR=7.98, p<0.0001) were associated with increased CAL risk in KD patients.
▶Dopamine receptor D3 genotype association with greater acute positive symptom remission with olanzapine therapy in predominately caucasian patients with chronic schizophrenia or schizoaffective disorderReviewDavid H. Adams et al.(2008)· Human Psychopharmacology: Clinical and Experimental
Literature review of 77 publications examining the effects of genes COMT, MAO-A, MAO-B, DAT, DRD2, VMAT2, TPH2, and SNCA on Parkinson's disease neuropsychiatric symptoms and therapy response. Key polymorphisms include rs1800497 (DRD2) associated with impulse control disorders, rs6269/rs4633/rs4818/rs4680 (COMT) with cognitive decline, and rs1352250/rs6582078 (TPH2) with impulse control. The review identifies genetic predictors for early complications (cognitive decline, depression, psychosis, impulse control disorders) and therapy optimization, relevant for patient selection for deep brain stimulation.
▶HTR2C and HTR1A gene variants in German and Italian suicide attempters and completersMeta-analysisN=32,750Alessandro Serretti et al.(2007)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
This dissertation investigated the genetic basis of violent criminal behavior, antisocial personality disorder (ASPD), and broader antisocial behavior through GWAS and meta-analyses in Finnish and international populations. Study I identified an intronic CDH13 variant (rs11649622, OR=2.7, p=4.19×10⁻⁶) associated with extremely violent offending, replicated in homicide offenders (p=5.3×10⁻⁷, OR=2.17). Study II revealed the first genome-wide significant association between LINC00951 variant rs4714329 (OR=1.59, p=1.6×10⁻⁹) and ASPD. Study III meta-analysis of 16,400 individuals found no genome-wide significant associations with broader antisocial behavior, though polygenic risk scores explained ~5% of phenotypic variance.
▶Association between the TPH gene A218C polymorphism and suicidal behavior: A meta‐analysisReviewFrank Bellivier et al.(2004)· American Journal of Medical Genetics Part B: Neuropsychiatric Genetics
This literature review compares genetic and non-genetic contributions of serotonin to suicide risk. The paper examines polymorphisms in serotonin-related genes (TPH, SLC6A4/5-HTT, HTR1A, HTR2A) and non-genetic factors including cerebrospinal fluid 5-HIAA levels and serotonin receptor binding abnormalities. Key findings indicate that reduced serotonin transporter expression (linked to 5-HTTLPR short allele), TPH polymorphisms, and HTR2A variants are associated with increased suicide vulnerability, though results are often inconsistent and require larger-scale studies.
▶A Tryptophan Hydroxylase Gene Marker for Suicidality and AlcoholismReviewDavid A. Nielsen et al.(1998)· Archives of General Psychiatry
This review article systematically examines the genetic and non-genetic contributions of serotonin to suicide risk. Key findings include associations between suicide and polymorphisms in serotonin pathway genes including TPH (A779C, A218C), 5-HTT/SLC6A4 (5-HTTLPR), HTR1A (C-1018G), and HTR2A (T102C, A-1438G, his452tyr), though findings are inconsistent across studies. The review also discusses non-genetic factors such as reduced cerebrospinal fluid 5-HIAA levels and abnormal serotonin receptor densities in postmortem brains of suicide victims.
About TPH2
This gene encodes a member of the pterin-dependent aromatic acid hydroxylase family. The encoded protein catalyzes the first and rate limiting step in the biosynthesis of serotonin, an important hormone and neurotransmitter. Mutations in this gene may be associated with psychiatric diseases such as bipolar affective disorder and major depression. [provided by RefSeq, Feb 2016]
View all TPH2 variants →Gene information from NCBI Gene. Variant classifications from ClinVar.
Community Wiki
No community notes yet for this variant. Sign in to start one.
Comments
Sign in to join the discussion.
Loading comments…